How Does Wegovy Dosing Work? Navigating Your Weight Loss Journey

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide medications like Wegovy work by activating GLP-1 receptors that regulate appetite and blood sugar, but the dose you take matters less than how your body responds to it. Most patients begin at a low starting dose and progress upward over 16–20 weeks, a strategy that reduces nausea and allows for better tolerability. PlexusDx offers compounded semaglutide injection at a flat rate at $189/mo month-to-month, or from $149/mo on the 6-month plan, meaning your dose can increase without increasing your cost.

What Is the Standard Semaglutide Dosing Schedule?

Semaglutide titration follows a structured four-phase protocol designed to help your body adjust gradually. Week 1–4 begins at 0.25 mg weekly, a dose that activates GLP-1 signaling while staying below the threshold for severe nausea in most patients. Weeks 5–8 increase to 0.5 mg as your tolerance improves and your appetite suppression deepens. This phased approach matches clinical trial data showing improved adherence and symptom management compared to rapid escalation.

Weeks 9–12 typically move to 0.75 mg, and weeks 13–16 reach 1.0 mg, the most common maintenance dose for weight loss results. Some patients continue to 1.7 mg or 2.4 mg in later weeks if tolerated and if clinical response warrants it. The key principle is that each dose increase happens only after you've adapted to the previous level, reducing the likelihood of severe side effects that might derail your progress.

Why Does Dose Titration Matter for Weight Loss Results?

Gradual dose increases allow your gastrointestinal system to become accustomed to semaglutide's appetite-suppressing effects without overwhelming you with nausea or vomiting. Research shows that patients who follow a slower titration schedule report better quality of life and higher treatment persistence than those who escalate too quickly. Starting low and going slow also gives you time to adjust your eating habits and meal sizes in sync with your medication's effects.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

What Happens When You Reach Your Maintenance Dose?

Once you reach your effective maintenance dose—typically 1.0 mg to 2.4 mg weekly—you stay at that level for as long as you continue treatment. Unlike antibiotics or other medications, semaglutide doesn't require dose escalation over time due to tolerance buildup; your body maintains sensitivity to the medication across months and years. Many patients stabilize their weight loss at the maintenance phase and use this period to reinforce lifestyle changes like meal planning and physical activity.

If you notice your appetite suppression weakening after several months at maintenance, your provider may suggest a brief pause, a dose adjustment, or a switch to a combination therapy like PlexusDx's GLP-Squared (semaglutide plus tirzepatide) to break through a plateau. The cost of semaglutide injection remains flat at $189/mo (or $149/mo on the 6-month plan) regardless of whether you're at 0.25 mg or 2.4 mg, so advancing your dose never increases your financial burden.

How Does PlexusDx Personalize Your Dosing Protocol?

The PlexusDx Precision Peptide Genetic Test ($298) analyzes FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

All PlexusDx semaglutide is compounded in licensed 503A pharmacies and available across all 50 states without insurance requirements or membership fees. Your dose may advance over weeks or months, but your price remains stable at $149 per month across the entire dosing range, ensuring you're never penalized for finding the right dose for your body. HSA and FSA accounts are also eligible for PlexusDx treatments, further reducing your out-of-pocket cost.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I skip ahead in the dosing schedule if I tolerate it well?

Accelerating your titration beyond the standard 4-week intervals is not recommended without your provider's approval, as it increases the risk of severe nausea, vomiting, and dehydration. Your PlexusDx provider will monitor your progress and may adjust your timeline based on your tolerance and goals, but the slower approach has the strongest clinical evidence for safety and adherence.

What clinical evidence supports the gradual titration approach?

Randomized controlled trials of semaglutide (STEP trials) demonstrated that patients following the standard 16-week titration achieved 15–18% weight loss with manageable side effects, while rapid dosing schedules resulted in higher discontinuation rates due to gastrointestinal symptoms. Gradual escalation optimizes both safety and efficacy.

How much does semaglutide cost at different dose levels with PlexusDx?

PlexusDx charges a flat rate of $189 per month for compounded semaglutide injection, regardless of your current dose or future dose increases. This means your price remains constant whether you're at 0.25 mg or 2.4 mg, eliminating the financial barrier to dose optimization.

What are the most common side effects during dose increases?

Nausea, mild vomiting, and reduced appetite are expected during the first 1–2 weeks after each dose increase; these typically resolve within days as your body adapts. Severe or persistent nausea may signal that you should slow your titration, and your PlexusDx provider can help adjust your schedule to improve comfort.

How does the Precision Peptide Genetic Test help with dosing decisions?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.